Biologic immunomodulators: Difference between revisions

(Created page with "==Background== *Immunomodulators created by a mouse or human cell that either create antibodies or targets against various cell lines that are receptor based. They interact wi...")
 
Line 4: Line 4:


==Naming==
==Naming==
The variious letters chosen in the name indicated the strucutre, origin, and targets of the molecule. For example ixekizumab for psoriasis ends with –mab, so it is a monoclonal antibody, has a –u- so it is human and has –ki- which means that it is interleukin targeted.
The various letters chosen in the name indicated the structure, origin, and targets of the molecule. For example ixekizumab for psoriasis ends with –mab, so it is a monoclonal antibody, has a –u- so it is human and has –ki- which means that it is interleukin targeted.  
===Suffix===
===Suffix===
*'''-mab''' means a monoclonal antibody
*'''-mab''' means a monoclonal antibody

Revision as of 19:28, 20 June 2019

Background

Naming

The various letters chosen in the name indicated the structure, origin, and targets of the molecule. For example ixekizumab for psoriasis ends with –mab, so it is a monoclonal antibody, has a –u- so it is human and has –ki- which means that it is interleukin targeted.

Suffix

  • -mab means a monoclonal antibody
  • –cept indicates a protein that mimics an immunoglobulin.

Middle syllable

  • –u- means all human derived
  • -o- means all mouse derived
  • -zu- means humanized after being mouse derived
  • –xi- means part-human and part-non human.

Middle bridging syllable

This lettering can indicate the biologic's target

  • t- means tumor is the target.
  • –ba- means there is bacterium target.
  • –so- means bone is targeted.
  • –ci- targets circulation.
  • –fu- targets fungus.
  • –gro- targets growth factor.
  • –ki- or –li- which means it is interleukin or immune targeted.

Adverse events

Special considerations

  • No live vaccines should be given to these patients.


References